What is the average wait time to see a neurologist?
Older people wait an average of just over a month to see a neurologist for specialty care after being referred by their primary care physician or another physician,… read more.
Older people wait an average of just over a month to see a neurologist for specialty care after being referred by their primary care physician or another physician,… read more.
Researchers from a large meta-analysis of relevant studies have reported that the average life expectancy of people with dementia at time of diagnosis ranges from 5.7 years at… read more.
A new Tulane University study suggests the Mediterranean diet’s brain-boosting benefits may work by changing the balance of bacteria in the gut. In a study published in Gut Microbes Reports, researchers… read more.
Researchers report that most treatments for pregnant women with MS (multiple sclerosis) do not lead to increased risks of major adverse outcomes. “We found that most therapies were… read more.
Atogepant, an oral drug approved to prevent migraine, appears to also alleviate migraine symptoms early after onset has begun. The findings were reported on December 23, 2024 in… read more.
Use of antibiotics by healthy elderly persons does not cause an increase in the risk of cognitive impairment or dementia, researchers reported on December 18, 2024 in Neurology…. read more.
Higher cardiorespiratory fitness in older age is linked to the preservation of several core aspects of cognitive ability that are vulnerable to age-related decline, finds research published online… read more.
Children of mothers who took certain antiseizure medications while pregnant do not have worse neurodevelopmental outcomes at age 6, according to a long-running study funded by the National… read more.
In cognitive science, there has recently been increasing attention to the relationship between sports expertise and working memory. However, to date, no meta-analysis has compared the working memory… read more.
A common yet underdiagnosed sleep disorder contributes to the development of dementia among adults — particularly women, a Michigan Medicine study suggests. Investigators uncovered this by examining survey… read more.
Eisai Co., Ltd and Biogen Inc. announced that the latest findings for lecanemab-irmb (U.S. brand name: Leqembi), an anti-amyloid beta (Aβ) protofibril antibody for the treatment of early… read more.
Polypharmacy, commonly defined as taking five or more medications daily, is a significant health care concern impacting over 30% of older adults. It is associated with poor health outcomes like… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.